Skip to main content

Table 1 Mean (±SD) age at onset, death and duration of illness for groups of patients with FTD, FTD + MND or MND associated with expansions in C9ORF72 , or mutations in GRN , or not known to be associated with any known FTLD or MND associated genes

From: Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72

Group

M/F

Age at onset (y)

Age at Death (y)

Duration of illness (y)

C9ORF72 FTD

7/1

61.1 ± 8.5

67.6 ± 7.0

6.5 ± 3.0

C9ORF72 FTD + MND

2/4

58.8 ± 6.1

64.7 ± 5.8

5.8 ± 6.2

C9ORF72 MND

6/1

55.8 ± 8.6

57.6 ± 7.6

2.8 ± 1.7

All C9ORF72 cases

15/6

58.9 ± 7.8

63.4 ± 7.9

5.2 ± 4.1

GRN FTD

7/5

60.8 ± 5.9

69.7 ± 3.9

8.8 ± 3.8

Non-mutational FTD

2/2

60.8 ± 11.9

68.0 ± 15.6

7.3 ± 4.1

Non-mutational FTD + MND

9/1

59.3 ± 7.0

65.4 ± 8.2

6.2 ± 3.8

All non-mutational FTD

11/3

59.6 ± 12.7

63.4 ± 13.6

2.4 ± 1.1

Non-mutational MND

12/8

59.7 ± 8.2

66.1 ± 10.2

6.5 ± 3.8

  1. FTD = Frontotemporal Dementia, FTD + MND + Frontotemporal dementia and Motor Neurone disease, MND = Motor Neurone Disease.